Valiant Organics Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹232Cr
- +13.7% YoY
- +6.4% QoQ
- Net profit
- ₹29Cr
- +262.5% YoY
- +81.3% QoQ
- Margin
- 18%
- +6 pp YoY
- +6 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Valiant Organics Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Revenue from Operations for Q1-FY27: INR 2,315 million - Year-on-year (YoY) growth in Revenue: 13.3% increase from INR 2,044 million in Q1-FY26 (Page 13, 12) - Total Revenue reported as INR 2,342 million for Q1-FY27 with 14% YoY growth (Page 10) - Sales volumes by chemistry for Q1-FY27 (metric tons): - Chlorination: approx. Q1-FY27 EBITDA: INR 416 million - EBITDA Margin: 17.97% - Year-on-Year EBITDA Growth: 67.7% (from INR 248 million in Q1-FY26) - EBITDA Margin Increase: +584 basis points YoY
From Valiant Organics Ltd's Q1 FY27 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Revenue from Operations for Q1-FY27: INR 2,315 million
- Year-on-year (YoY) growth in Revenue: 13.3% increase from INR 2,044 million in Q1-FY26 (Page 13, 12)
- Total Revenue reported as INR 2,342 million for Q1-FY27 with 14% YoY growth (Page 10)
- Sales volumes by chemistry for Q1-FY27 (metric tons):
- Chlorination: approx. 440 MT
- Hydrogenation: approx. 478 MT
- Ammonolysis: approx. 513 MT
2 more points from Valiant Organics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.
Valiant Organics Ltd — Quarterly revenue & net profit
Valiant Organics Ltd Q1 FY27 results — key figures
| ₹ Cr | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 232 | 204 | +13.7% | 218 | +6.4% |
| Operating profit (EBITDA) | 42 | 25 | +68% | 26 | +61.5% |
| Operating margin | 18% | 12% | +6 pp | 12% | +6 pp |
| Profit before tax | 37 | 11 | +236.4% | 18 | +105.6% |
| Net profit (PAT) | 29 | 8 | +262.5% | 16 | +81.3% |
| EPS (₹) | 10.36 | 2.93 | +253.6% | 5.61 | +84.7% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Valiant Organics Ltd Q1 FY27 results?
Revenue from Operations for Q1-FY27: INR 2,315 million - Year-on-year (YoY) growth in Revenue: 13.3% increase from INR 2,044 million in Q1-FY26 (Page 13, 12) - Total Revenue reported as INR 2,342 million for Q1-FY27 with 14% YoY growth (Page 10) - Sales volumes by chemistry for Q1-FY27 (metric tons): - Chlorination: approx. Q1-FY27 EBITDA: INR 416 million - EBITDA Margin: 17.97% - Year-on-Year EBITDA Growth: 67.7% (from INR 248 million in Q1-FY26) - EBITDA Margin Increase: +584 basis points YoY
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
